Name: UMIN ID:
Unique ID issued by UMIN | UMIN000020585 |
---|---|
Receipt number | R000023766 |
Scientific Title | Investigator initiated Phase II Study of Gedatolisib in Advanced Recurrent Small-Cell Lung Cancer Patients harboring Molecular Alterations in PI3K/AKT/mTOR Pathway |
Date of disclosure of the study information | 2016/02/01 |
Last modified on | 2020/08/12 08:36:51 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2016/01/15 18:51:44 | ||
2 | Update | 2016/02/12 09:35:07 | Primary outcomes Primary outcomes |
|
3 | Update | 2016/02/12 09:36:36 | Acronym Acronym |
|
4 | Update | 2016/03/01 12:22:05 | Recruitment status Anticipated trial start date |
|
5 | Update | 2016/12/14 09:32:39 | Recruitment status |
|
6 | Update | 2017/01/16 08:51:26 | Narrative objectives1 |
|
7 | Update | 2017/01/16 08:55:20 | Division name Name of primary person or sponsor Organization Category of Funding Organization |
|
8 | Update | 2017/01/16 09:05:17 | Institutions |
|
9 | Update | 2017/06/16 09:25:43 | Key exclusion criteria |
|
10 | Update | 2020/01/17 09:56:44 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Address Last name of contact person Last name of contact person Zip code Address Organization Organization Address Address Tel |
|
11 | Update | 2020/01/17 10:03:28 | Date of IRB Last follow-up date |
|
12 | Update | 2020/07/20 08:38:19 | Recruitment status |
|
13 | Update | 2020/08/12 08:36:51 | Recruitment status |